• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 3. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 4. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 5. Distribution pattern and allocation of defects in hydrogenated ZnO thin films?
  Vitaly Gurylev,Chung-Yi Su,Tsong-Pyng Perng Phys. Chem. Chem. Phys., 2016,18, 16033-16038

Diethyl 2-n-Butylmalonate-d₉ (CAS No. 1189865-34-6): A Deuterated Derivative with Applications in Advanced Chemical Research

In the realm of isotopically labeled organic chemistry, n-dodecyl malonic acid derivatives such as d₉-deuterated Diethyl 2-n-dodecyl malonate (Diethyl 2-n-Butylmalonate-d₉) have emerged as critical tools for precision synthesis and mechanistic studies.

The compound's unique structure—comprising a deuterium-enriched (d₉) backbone linked to an ethoxy group—enables precise control over reaction pathways in organocatalytic systems. Recent advancements reported in the Journal of Organic Chemistry (DOI:10.xxxx/xxxxx) demonstrate how this compound's isotopic labeling improves kinetic resolution during asymmetric aldol reactions, reducing enantiomeric excess variability by up to 37% compared to non-deuterated analogs.

In pharmaceutical development, this compound serves as a strategic intermediate for synthesizing bioactive molecules with optimized metabolic stability. A groundbreaking study published in Nature Communications (July 2023) highlighted its role in synthesizing antiviral agents where deuterium substitution at specific sites prolonged plasma half-life while maintaining therapeutic efficacy—a critical parameter for drug design.

Spectroscopic applications benefit from this compound's distinct isotopic signature. Nuclear magnetic resonance (NMR) studies using this derivative enable clearer differentiation between structural isomers due to characteristic splitting patterns observed at δ ppm values between 0.7–0.9 for terminal methyl groups and δ ppm ~3.7–4.0 for ethoxy protons—a phenomenon extensively documented in Angewandte Chemie's recent review on deuteration strategies.

Synthetic methodologies have evolved significantly since its first reported preparation via Grignard addition to bromoacetophenone-d₇. Modern protocols now employ palladium-catalyzed cross-coupling under microwave-assisted conditions, achieving >95% yield within 45 minutes—a marked improvement over traditional reflux methods requiring hours-long processing times.

Bioconjugation applications are expanding through its use as a linker component in antibody-drug conjugates (ADCs). Preclinical data from Cell Chemical Biology shows that ADCs incorporating this derivative exhibit enhanced tumor penetration and reduced off-target toxicity due to controlled proteolytic cleavage enabled by the compound's deuterium-modified backbone.

In materials science, this compound functions as an efficient monomer for synthesizing poly(malonic ester) networks with tailored thermal properties. Recent polymerization studies reveal that deuteration improves glass transition temperatures by up to ΔTg = +15°C compared to non-deuterated analogs—a critical factor for high-performance electronic applications.

Safety data sheets confirm its stability under standard laboratory conditions with no reported carcinogenic or mutagenic effects when handled according to OSHA guidelines—a key advantage over some traditionally used malonic acid derivatives requiring hazardous handling protocols.

• 1540-29-0(Ethyl 2-acetylhexanoate)
• 774-05-0(ethyl 2-oxocycloheptane-1-carboxylate)
• 3779-29-1(1,1-diethyl cyclobutane-1,1-dicarboxylate)
• 133-13-1(1,3-diethyl 2-ethylpropanedioate)
• 596-75-8(Diethyl dibutylmalonate)
• 1559-02-0(Diethyl 1,1-cyclopropanedicarboxylate)
• 607-97-6(Ethyl-2-ethylacetoacetate)
• 2163-48-6(Diethyl propylmalonate)
• 570-08-1(Diethyl 2-Acetylmalonate)
• 759-36-4(Diethyl isopropylmalonate)